Preclinical & Toxicology

QS Pharma can identify the means to dose a compound to a preclinical animal species. The identified formulation results in the desired biologic exposure, presents the compound in a surrogate for an ultimate commercial formulation and produces no untoward effects due to the excipients in the formulation. The formulations are identified for individual compounds for discreet studies or in complex mixtures for combinatorial pharmacokinetics studies.